Compare Abeona Therapeutics Inc (ABEO) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs EPR Properties — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while EPR Properties trades at $60.3 (market cap $4.58B). The key difference: EPR Properties is far larger — about 10.9× Abeona Therapeutics Inc's market cap, and EPR Properties pays a 6.22% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | EPR | |
|---|---|---|
Market Cap | $421.19M | $4.58B |
Sector | Health | Real Estate |
52-Week High | $7.45 | $64.32 |
52-Week Low | $4.17 | $48.71 |
Enterprise Value | $276.10M | $8.09B |
Dividend Yield | — | 6.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
